声明
摘要
Abstract
Contents
Abbreviations
Introduction
Background
The aim of study
1.Methods
1.1 Study Population
1.2 Plasma collection and storage
1.3 Extraction of miRNA
1.4 Reverse transcription
1.5 RT-PCR
1.6 Laboratory assay
1.7 Statistical analysis
2 Results
2.1 Clinical characteristics of the study population
2.2 Plasma miR-208a and miR-208b elevated in patients with acute STEMI
2.3 Plasma miR-208a and miR-208b concentration and cTnI
2.4 Receiver operating characteristic(ROC)analysis
2.5 miRNAs and plasma levels of h-FABP in acute STEMI
2.6 miRNAs and plasma levels of hs-CRP in acute STEMI
2.7 Clinical correlations
2.7.1 Lipid profiles and cardiac specific miRNAs
2.7.2 miRNAs and Left ventricular systolic function
3.Discussion
3.1 Circulating miR-208a and miR-208b as biomarker in AMI
3.2 Circulating miR-208 correlations with LVEF and other biomarkers
3.3 Limitations
Conclussion
Papers innovations
Reference
Published papers
Literature review Acute myocardial infarction and miRNA 208
Acknowledgements
天津医科大学;